Humanigen, Inc. HGEN

New IPO $MRAI today, target $20, now only $5, AI Technology Company

$HGEN I lost a fortune on this stock. I do not trust the company leadership.

$HGEN Once upon a time, the FDA was serious about covid and doing everything in their power to fight it and suppress its deadly effects. But with a different administration comes new direction which does not seem to include Humanigen’s lenzilumab.

It is NOT about scrutiny of the data. It is politics in the FDA that is keeping lenzilumab from receiving Emergency Use!

The FDA seems to also believe covid is over despite increasing cases and deaths. What will it take?

$HGEN This has to be the longest wait time for EUA. I think Biden is pushing the FDA to prioritize full approval of vaccines over MAB treatment EUAs.

What stock market are you looking at. The medicine for this is the one being created by Merck. Everybody else must wait !

$HGEN I have been waiting a long time for lenz EUA, but I am skeptical about a 2X or 3X increase in the stock price based on EUA.

Is there a chart someone can share showing price impact on other stock prices when they received EUA?

$HGEN Anyone know why this stock is so suppressed? Somebody’s holding this back big time. I’m hoping for EUA in the next couple weeks. When it comes this will take off!

Im late. Shit . GLA.,hopefully trend stays in the same direction for two weeks and you make plenty money.

$HGEN Since Oct’20, declining trends for $HGEN stock have lasted 7 days (-55%), 10 days (-76%), 7 days (-51%), 16 days (-66%, -120% if you count the high of 29.20), 7 days (-21%), 4 days (-32%), and currently 15 days (-34%) and counting before turning around.

This current price decline is not as steep as in the past, mostly because the EUA is a shoe-in for approval, but it will be one of the longest declining trends.

$HGEN Anyone else notice how stable this price action is? Very tightly controlled. This thing is setting up for a very good increase.

I think we might be close to getting some good news on EUA. Also, it wouldn’t surprise me if we got some unexpected news on some of their other drug trials. It wasn’t lenzilumab that caused that big run up from 13 to 22 in December. Humanigen has more going on than the blaringly obvious EUA on the table.